ArticleACG case reports journal2025
Primary Jejunal Angiosarcoma.
Article in ACG case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary jejunal angiosarcoma is an aggressive and rare soft-tissue neoplasm with a poor prognosis. Multiple modalities such as endoscopic intervention, radiographic imaging, and immunohistochemistry are often used to confirm the diagnosis. Only 62 cases have been reported in the literature of primary jejunal angiosarcoma, and the majority of these patients had distant metastases at initial staging. This is a case of a 51-year-old man who presented with melena found to have a jejunal mass and diagnosed with angiosarcoma with no metastases detected on initial staging. The diagnosis of angiosarcoma was confirmed with histomorphology and immunohistochemistry. Despite early tumor staging and successful small bowel resection, 6 months postsurgical resection patient later presented with metastatic. This case report highlights the importance of a comprehensive diagnostic strategy and raises consideration for earlier systemic therapy in localized neoadjuvant therapy in early-stage small bowel angiosarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.